TLPH Q1 2020 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q1 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$386,000+45.7% YoY

Gross Profit

-$1M-291.5% margin

Operating Income

-$16M-4105.7% margin

Net Income

-$16M-4125.6% margin

EPS (Diluted)

$-3.98

QoQ Revenue Growth

-18.7%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$77M

Total Liabilities

$133M

Stockholders' Equity

-$55M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$386,000	$265,000	+45.7%
Gross Profit	-$1M	-$2M	+52.0%
Operating Income	-$16M	-$12M	-28.7%
Net Income	-$16M	-$14M	-16.5%